I

Indépendant

8 employees

CardiaLen develops and commercializes pain-free cardioversion therapies for atrial fibrillation.

Basic info

Industry

medical equipment manufacturing

Sectors

Biotechnology
Life Science
Cardiac Rhythm Management
Medical Device
Atrial fibrillation detection and treatment
implantable cardiac device

Date founded

2008

Funding rounds raised

Total raised

$17M

from 11 investors over 11 rounds

I

Indépendant raised $2.8M on January 19, 2021

Investors: National Institutes of Health

I

Indépendant raised $17M on October 10, 2018

Investors: RiverVest Venture Partners, Cultivation Capital and Qiming Venture Partners

I

Indépendant raised $300K on August 26, 2016

Investors: Cultivation Capital

I

Indépendant raised $1.5M on March 26, 2015

Investors: Lambda Fund Management Inc, BELLE Capital USA LP, St. Louis Arch Angels, Cultivation Capital and Heartland Angels

I

Indépendant raised $138K on September 1, 2012

Investors: St. Louis Arch Angels

FAQ